| HOME >> BIOLOGY >> TECHNOLOGY |
WASHINGTON, Feb. 4 /PRNewswire/ -- A recent study published this month in the journal, Pediatrics, suggests that the use of baby lotion, powder, and shampoo is linked to the presence of phthalates in babies. Phthalates are a large family of compounds used in a wide variety of everyday products. They are used primarily as plasticizers, giving flexibility to rubber, plastic, or resin and can also be used to stabilize and make fragrances work properly. The study's researchers analyzed urine concentrations of nine different phthalate metabolites in 163 infants and concluded that the use of these baby products resulted in higher levels of phthalates in the infants. John Bailey of the Personal Care Products Council issued the following statement:
"The results of this study suggesting a link between the use of baby lotion, shampoo, and powder and the presence of phthalates in infants do not make sense because only one of the seven phthalate compounds reported is even used in baby care products. This suggests that most of the phthalates found in the urine samples came from another route of exposure, and we welcome additional study to determine the source.
"The one phthalate that is sometimes found in baby care products is diethyl phthalate (DEP). DEP, which is a component of some fragrance preparations, may be present at very low levels in baby care products. No other phthalates are used in fragrance ingredients. Both the Cosmetic Ingredient Review (CIR) Expert Panel, an independent, nonprofit panel of scientists and physicians who assess the safety of personal care product ingredients in the U.S., and the Scientific Committee on Consumer Products (SCCP), the body that advises the European Union Commission on safety matters related to cosmetics, determined DEP to be safe. DEP has been extensively researched and is not linked to reproductive toxicity or endocrine disruption.
"Unfortunately, the researchers of this study did not test baby care
prod
'/>"/>
| SOURCE Personal Care Products Council Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
2. Smithfield Foods, Inc. Statement Regarding Animal Cloning
3. Statement on the Release of the European Food Safety Assessment on the Safety of Food Derived From Clones and Their Offspring in the Food Supply
4. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
5. /CORRECTION//- RxElite Temporarily Suspends Sales Under Its Registration Statement
6. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
7. Statement of International Dairy Foods Association President and CEO Connie Tipton
8. National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC
9. Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement and Release Date of Third Quarter 2007 Financial Results
10. CCPM Issues Statement on FDAs GIVE Initiative
11. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |